Acute myeloid leukemia: a retrospective claims analysis of resource utilization and expenditures for newly diagnosed patients from first-line induction to remission and relapse

References

• American Cancer Society. Acute Myeloid Leukemia. Available at: http://www.cancer.org/cancer/leukemia-acutemyeloidaml/index [Last accessed 7 December 2016]
   Google Scholar
• Ramos NR, Mo CC, Karp JE, Hourigan CS. Current approaches in the treatment of relapsed and refractory acute myeloid leukemia. J Clin Med 2015;4:665-95
   PubMed Web of Science ®Google Scholar
• Walter RB, Othus M, Burnett AK, et al. Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center. Leukemia 2015;29:312-20
   PubMed Web of Science ®Google Scholar
• Surveillance, Epidemiology, and End Results (SEER). National Cancer Institute. SEER Stat Fact Sheets: Acute Myeloid Leukemia. Available at: http://seer.cancer.gov/statfacts/html/amyl.html [Last accessed 7 December 2016]
   Google Scholar
• National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology. Version 2.2016, Available at: https://www.nccn.org/professionals/physician_gls/pdf/aml.pdf [Last accessed 7 December 2016]
   Google Scholar
• American Cancer Society. Typical treatment of most types of acute myeloid leukemia. Available at: http://www.cancer.org/cancer/leukemia-acutemyeloidaml/detailedguide/leukemia-acute-myeloid-myelogenous-treating-typical-treatment-of-aml [Last accessed 7 December 2016]
   Google Scholar
• Jones CV, Copelan EA. Treatment of acute myeloid leukemia with hematopoietic stem cell transplantation. Future Oncol 2009;5:559-68
   PubMed Web of Science ®Google Scholar
• Dohner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. N Engl J Med 2015;373:1136-52
   PubMed Web of Science ®Google Scholar
• Hamilton BK, Copelan EA. Concise review: the role of hematopoietic stem cell transplantation in the treatment of acute myeloid leukemia. Stem Cells 2012;30:1581-6
   PubMed Web of Science ®Google Scholar
• Estey E. Reducing mortality associated with immediate treatment complications of adult leukemias. Semin Hematol 2001;38:32-7
   PubMed Web of Science ®Google Scholar
• Walter RB, Taylor LR, Gardner KM, et al. Outpatient management following intensive induction or salvage chemotherapy for acute myeloid leukemia. Clin Adv Hematol Oncol 2013;11:571-7
   PubMedGoogle Scholar
• Mahmoud D, Skikne BS, Kucmin-Bemelmans I, et al. Overall economic burden of total treatment costs in acute myeloid leukemia throughout the course of the disease. ASH Annual Meeting: Oral and Poster Abstracts, 8–11 December 2012, Atlanta, GA, USA
   Google Scholar
• Menzin J, Lang K, Earle CC, et al. The outcomes and costs of acute myeloid leukemia among the elderly. Arch Intern Med 2002;162:1597-603
   PubMed Web of Science ®Google Scholar
• LeBlanc TW, Wolf S, Davis DM, et al. Symptom burden, quality of life, and distress in acute myeloid leukemia patients receiving induction chemotherapy: a prospective electronic patient-reported outcomes study. J Clin Oncol 2015;33:abstract e20702
   Web of Science ®Google Scholar
• Meyers J, Yu Y, Kaye JA, Davis KL. Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs. Appl Health Econ Health Policy 2013;11:275-86
   PubMedGoogle Scholar
• Katz LM, Howell JB, Doyle JJ, et al. Outcomes and charges of elderly patients with acute myeloid leukemia. Am J Hematol 2006;81:850-7
   PubMed Web of Science ®Google Scholar
• Medeiros BC, Satram-Hoang S, Hurst D, et al. Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United States. Ann Hematol 2015;94:1127-38
   PubMed Web of Science ®Google Scholar
• Clavio M, Quintino S, Masoudi B, et al. Cost of de novo acute myeloid leukemia induction therapy in adults: analysis of EORTC-GIMEMA AML10 and FLANG regimens. J Exp Clin Cancer Res 2001;20:165-73
   PubMed Web of Science ®Google Scholar
• Smith BD, Beach CL, Mahmoud D, et al. Survival and hospitalization among patients with acute myeloid leukemia treated with azacitidine or decitabine in a large managed care population: a real-world, retrospective, claims-based, comparative analysis. Exp Hematol Oncol 2014;3:10
   PubMedGoogle Scholar
• Wang HI, Aas E, Howell D, et al. Long-term medical costs and life expectancy of acute myeloid leukemia: a probabilistic decision model. Value Health 2014;17:205-14
   PubMed Web of Science ®Google Scholar
• Nerich V, Lioure B, Rave M, et al. Induction-related cost of patients with acute myeloid leukaemia in France. Int J Clin Pharm 2011;33:191-9
   PubMed Web of Science ®Google Scholar
• Boehme A, Atta J, Mousset S, et al. Change of antifungal treatment patterns and associated costs in patients with acute myelogenous leukemia (AML) after chemotherapy in a German hospital from 2004 to 2006. Value Health 2010;13:A259-60
   Google Scholar
• Leunis A, Blommestein HM, Huijgens PC, et al. The costs of initial treatment for patients with acute myeloid leukemia in the Netherlands. Leuk Res 2013;37:245-50
   PubMed Web of Science ®Google Scholar
• Philip C, George B, Ganapule A, et al. Acute myeloid leukaemia: challenges and real world data from India. Br J Haematol 2015;170:110-17
   PubMed Web of Science ®Google Scholar
• Hansen LG, Chang S. White Paper. Health Research Data for the Real World: The MarketScan Databases. Thomson Reuters, New York, NY, 2012
   Google Scholar
• Stedman MR, Mariotto AB, Klabunde CN, et al. A revised SAS macro for computing the Charlson score. Poster presented at: National Cancer Institute. Available at: http://www.naaccr.org/LinkClick.aspx?fileticket=VLucilIwujE%3D&tabid=265&mid=742 [Last accessed 9 August 2016]
   Google Scholar
• US Bureau of Labor Statistics, Consumer Price Index Detailed Report, July 2014. Available at: http://www.bls.gov/cpi/cpid1407.pdf [Last accessed 8 December 2016]
   Google Scholar
• Kurosawa S, Yamaguchi T, Miyawaki S, et al. Prognostic factors and outcomes of adult patients with acute myeloid leukemia after first relapse. Haematologica 2010;95:1857-64
   PubMed Web of Science ®Google Scholar
• Stoiser B, Knobl P, Fonatsch C, et al. Prognosis of patients with a second relapse of acute myeloid leukemia. Leukemia 2000;14:2059-63
   PubMed Web of Science ®Google Scholar